-
Mashup Score: 4HCPLive | LinkedIn - 2 month(s) ago
HCPLive | 2,418 followers on LinkedIn. Comprehensive clinical news that provide physicians with up-to-date specialty and disease-specific information. | HCPLive provides health care professionals with up-to-date specialty and disease-specific news, clinical information, and other resources to help provide better care to patients. On HCPLive.com, you will find in-depth conference coverage and information about upcoming meetings, perspective on regulatory news, and multimedia content featuring key opinion leaders. Get all the latest news on individual medical conditions in our “condition centers”: • Cardiology • Endocrinology • Gastroenterology • Ophthalmology • Neurology • Pain Management • Pediatrics • Primary Care • Psychiatry • Rheumatology • Urology
Source: www.linkedin.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0Abrocitinib Effective for Eczema Patients with Inadequate Response to Upadacitinib, Dupilumab - 2 month(s) ago
This research also included results from a sub-analysis of non-responders with hand eczema to dupilumab and upadacitinib.
Source: www.hcplive.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0
Additional research on this form of moisturizer and other ingredients for acne with larger sample sizes may be needed to verify efficacy for acne vulgaris.
Source: www.hcplive.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 0Abrocitinib Effective for Eczema Patients with Inadequate Response to Upadacitinib, Dupilumab - 3 month(s) ago
This research also included results from a sub-analysis of non-responders with hand eczema to dupilumab and upadacitinib.
Source: www.hcplive.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0Abrocitinib Effective for Eczema Patients with Inadequate Response to Upadacitinib, Dupilumab - 3 month(s) ago
This research also included results from a sub-analysis of non-responders with hand eczema to dupilumab and upadacitinib.
Source: www.hcplive.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0
“Discover the latest partnership between Estée Lauder’s Clinique and Mount Sinai, creating a dermatology center to research skin health and develop solutions fo
Source: www.beckershospitalreview.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 6Lawrence Eichenfield, MD: On Verrica Receiving Permanent J-Code for Cantharidin Treatment of Molluscum - 3 month(s) ago
This segment of Eichenfield’s interview features a discussion about the recent announcement of a J-Code for the molluscum contagiosum treatment cantharidin.
Source: www.hcplive.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 1Eingun James Song, MD: Tips, Tricks for Dermatologists Treating Palmoplantar Psoriasis - 4 month(s) ago
In this discussion with E. James Song, MD, several unique clinical pearls for those in dermatology were described and had been drawn from Song’s Winter Clinical presentation.
Source: www.hcplive.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 2Deroofing, Laser Treatments Introduced for Patients in the UK with Hidradenitis Suppurativa - 4 month(s) ago
The THESEUS study was conducted to look at current HS management and the influences on treatment decisions, with the goal of informing future randomized controlled trials.
Source: www.hcplive.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0The Cutaneous Connection - 4 month(s) ago
Listen to The Cutaneous Connection on Spotify. From the latest updates in dermatology to exclusive interviews with leading industry experts and a glimpse at what goes on behind the scenes, the staff at Dermatology Times brings you a podcast that will explore the impact of new data and support you in implementing innovative technologies that advance your patient care and practice. Join us under the dermatoscope for The Cutaneous Connection.
Source: open.spotify.comCategories: General Medicine News, DermatologyTweet
🚨 We are days away from our Pre-AAD LinkedIn Chat on March 04! Follow us and check back on Monday at 8 PM ET for the first in our 6-question chat, which is free and requires no registration. Questions Highlighted in the next tweet! https://t.co/DUMjZBfnM1 #Dermatology https://t.co/7J1xiySh1d